Product Promotion. 8.1 The Products shall be featured in the Internet Store according to the specifications in the Product List.
Product Promotion. In accordance with the Marketing Plan, and subject to the Act and any applicable state laws and regulations, as well as the provisions of this Agreement, Reliant shall, at its sole expense (as between Reliant and Novartis), use its commercially reasonable efforts to promote the Product to Professionals, and to persuade such Professionals to prescribe and use the Product, through the use of verbal, graphic, written and promotional materials. All such statements, core selling messages and materials to be utilized by Reliant to promote the Product shall be consistent with the annual Marketing Plan jointly developed by Reliant and Novartis and, if applicable, shall be subject to the prior approval of the FDA in accordance with Article 4.8 below. Prior to January 1 of each of Agreement Years 2006 and 2007, Novartis shall provide to Reliant a list of Professionals to whom to promote the Product; provided, however, that Novartis shall have the right, in its sole discretion, to revise such list no more than two times during each of Agreement Years 2006 and 2007 by providing a revised list to Reliant prior to May 1 and/or November 1 of each such Agreement Year. In performing its obligations pursuant to this Agreement, Reliant will exercise the same diligence it employs with respect to the other products it promotes in the Territory (“Promotion Effort”). Reliant will cause the Sales Force and Reliant employees and agents acting on Reliant’s behalf to comply with this Agreement and all applicable state and federal laws and regulations in connection with the promotion, marketing and Detailing of the Product. It is understood, and Reliant agrees, that it will be accountable for any act or omission of the Sales Force to comply with Reliant’s obligations under this Agreement.
Product Promotion. (a) Subject to applicable Legal Requirements, as well as the provisions of this Agreement, Santarus shall, during the Term until Generic Entry of any Product (subject to Section 8.3(b)), at its sole expense, use commercially reasonable efforts to Promote the Products within the Territory in accordance with the Annual Plan (the “Promotional Effort”). For purposes of the preceding sentence, Santarus’ commercially reasonable efforts shall be met if Santarus is in compliance with its obligations under Section 5.1(b) and Section 5.1(c) of this Agreement. Santarus will cause the Santarus Sales Force and Santarus employees and agents acting on Santarus’ behalf to comply with this Agreement and all applicable Legal Requirements in connection with the Commercialization of the Products. It is understood, and Santarus agrees, that it will be accountable for the acts or omissions of the Santarus Sales Force and its employees and agents.
Product Promotion. Upon the terms and conditions set forth in this Agreement, Amylin hereby grants Lilly during the term of this Agreement the co-exclusive right with Amylin to promote and detail Product in the Co-Promotion Territory in accordance with the terms of this Agreement. The principal objective of the Parties hereunder is to maximize the commercialization of the Product in the Co-Promotion Territory. Following receipt of Marketing Approval in the Co-Promotion Territory, the Parties shall each use their Commercially Reasonable Efforts to promote Product in the Co-Promotion Territory and to fulfill their obligations under this Agreement. The Parties shall deploy each of their respective sales forces in an effort to promote the Product in the Co-Promotion Territory in accordance with the Commercialization Plan in effect from time to time, the directions of the JCC, and the terms of this Agreement. Prior to Product Launch, and thereafter or an annual basis, the JCC shall agree upon (i) the number of Details needed for the following year, (ii) the number of Details that must be made as First Priority Product, Second Priority Product or as a Secondary Detail, (iii) the Amylin Detail Percentage and the Lilly Detail Percentage, and (iv) the size of each party's Sales Force and Detail Position necessary to permit each party to fulfill its obligations under this Agreement. Notwithstanding the foregoing, unless the Parties agree otherwise, each Party will [...***...] to the promotion of the product.
Product Promotion. Licensees shall, and shall cause their Sublicensees to, use commercially reasonable efforts to promote, market and sell all categories of Licensed Products in commercial quantities into every country within the Territory. Licensor reserves the right to convert the license rights granted to all Licensees in Section 2.1 from an exclusive license to a non-exclusive license with respect to any specific Licensed Products in a country within the Territory in the event that no Licensee is selling commercially viable quantities of such Licensed Products into that country within five (5) years of the Distribution Date. Whether sales of Licensed Products rise to the level of commercially viable quantities shall be determined in good faith by the Parties upon review and consideration of current Net Sales, future projected Net Sales provided to Licensor and specific sales plans shared with Licensor for the specific products within the Territory.
Product Promotion. Buyer and Seller shall mutually agree on the level and extent of marketing aid and support that Seller will provide to Buyer during each twelve (12) month period following the Effective Date. Such aid may include, without limitation, marketing and promotion through Product Literature and print advertising.
Product Promotion. LSI Logic will actively promote Specman Plus to Mint customers following its production release.
Product Promotion. 4.1 Alco shall define with Sicor on or before the end of October of each year, the promotion plan for the sale of the Product to be implemented the following calendar year. Said plan may be modified on the basis of market conditions subject to the obligation of a reasonably sufficient promotion in relation to the budget (Article 2.1.8) and the minimum guaranteed sales (Article 2.1.1).
Product Promotion. DISTRIBUTOR shall exhibit and demonstrate the Products at such trade shows in the Territory as DISTRIBUTOR determines in good faith are necessary or useful in marketing and promoting the Products. DISTRIBUTOR shall give SpectraSCIENCE reasonable prior notice of all such trade shows such that SpectraSCIENCE can attend if it so desires. DISTRIBUTOR shall otherwise meet all reasonable business standards for displaying, demonstrating, and explaining the operation and use of the Products to customers and potential customers.
Product Promotion. US Bio will not provide any information regarding the safety, effectiveness, or use of Product to Specialty Pharmacy Customers or other persons or entities except as approved in advance in writing by Dyax or required by Applicable Laws. US Bio may provide information on its own specialty pharmacy and distribution services to its Specialty Pharmacy Customers in accordance with US Bio standard business practices, including informing its Specialty Pharmacy Customers of pricing available for the Product and other products distributed by US Bio. US Bio warrants that any information it provides to its Specialty Pharmacy Customers regarding Product or its services will be truthful and non-misleading and will comply with all Applicable Laws.
